Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer.
10.3904/kjim.2014.29.6.830
- Author:
Jeong Uk LIM
1
;
In Sook WOO
;
Yun Hwa JUNG
;
Jae Ho BYEON
;
Chan Kwon PARK
;
Tae Jung KIM
;
Hyo Rim KIM
Author Information
1. Division of Hematology and Oncology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. insookwoo@catholic.ac.kr
- Publication Type:Letter ; Case Reports
- Keywords:
Erlotinib;
Acquired resistance;
Neuroendocrine
- MeSH:
Adenocarcinoma/chemistry/*drug therapy/secondary;
Adult;
Antineoplastic Agents/*therapeutic use;
Biopsy;
Carcinoma, Large Cell/chemistry/*pathology;
Carcinoma, Neuroendocrine/chemistry/*pathology;
Carcinoma, Non-Small-Cell Lung/chemistry/*drug therapy/secondary;
*Drug Resistance, Neoplasm;
Humans;
Lung Neoplasms/chemistry/*drug therapy/pathology;
Magnetic Resonance Imaging;
Male;
Protein Kinase Inhibitors/*therapeutic use;
Quinazolines/*therapeutic use;
Tomography, X-Ray Computed;
Treatment Outcome;
Tumor Markers, Biological/analysis
- From:The Korean Journal of Internal Medicine
2014;29(6):830-833
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
